Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ICUI logo ICUI
Upturn stock ratingUpturn stock rating
ICUI logo

ICU Medical Inc (ICUI)

Upturn stock ratingUpturn stock rating
$135.03
Last Close (24-hour delay)
Profit since last BUY0%
upturn advisory
Consider higher Upturn Star rating
BUY since 1 day
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/11/2025: ICUI (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

6 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $186.2

1 Year Target Price $186.2

Analysts Price Target For last 52 week
$186.2 Target price
52w Low $117.92
Current$135.03
52w High $196.26

Analysis of Past Performance

Type Stock
Historic Profit 12.99%
Avg. Invested days 36
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/11/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.33B USD
Price to earnings Ratio -
1Y Target Price 186.2
Price to earnings Ratio -
1Y Target Price 186.2
Volume (30-day avg) 6
Beta 0.89
52 Weeks Range 117.92 - 196.26
Updated Date 07/6/2025
52 Weeks Range 117.92 - 196.26
Updated Date 07/6/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.83

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -3.87%
Operating Margin (TTM) 4.89%

Management Effectiveness

Return on Assets (TTM) 1.79%
Return on Equity (TTM) -4.62%

Valuation

Trailing PE -
Forward PE 20.66
Enterprise Value 4644162747
Price to Sales(TTM) 1.38
Enterprise Value 4644162747
Price to Sales(TTM) 1.38
Enterprise Value to Revenue 1.92
Enterprise Value to EBITDA 16.67
Shares Outstanding 24611900
Shares Floating 23848229
Shares Outstanding 24611900
Shares Floating 23848229
Percent Insiders 3.04
Percent Institutions 101.79

ai summary icon Upturn AI SWOT

ICU Medical Inc

stock logo

Company Overview

overview logo History and Background

ICU Medical, Inc. was founded in 1984. It initially focused on developing and marketing needlefree IV connectors and has grown through product innovation and strategic acquisitions to become a global player in infusion therapy and critical care products.

business area logo Core Business Areas

  • Infusion Consumables: Includes IV sets, solutions, and administration devices used to deliver fluids and medications to patients.
  • Infusion Systems: Encompasses infusion pumps and related software used to precisely control the delivery of fluids and medications.
  • Medication Delivery: Includes closed system transfer devices (CSTD) and other products used to safely prepare and administer hazardous drugs.
  • Other: Other solutions related to IV access, critical care monitoring, and patient safety.

leadership logo Leadership and Structure

Vivek Jain serves as the Chief Executive Officer. The company has a board of directors and operates with a functional organizational structure, with departments dedicated to research and development, manufacturing, sales and marketing, and finance.

Top Products and Market Share

overview logo Key Offerings

  • IV Solutions: These include a broad range of solutions like saline, dextrose, and lactated Ringer's used in IV therapy. Competition includes Baxter, B. Braun, and Fresenius Kabi. Market share data is difficult to pinpoint exactly, but the combined market represents billions in yearly sales. ICU Medical is a key player in the IV solutions market but not the leading single player.
  • Infusion Pumps: ICU Medical offers various infusion pumps used to deliver fluids and medications. Competitors include Baxter and BD. Market share data is fragmented, but the global infusion pump market is significant and split across a few key players. ICU Medical's marketshare is a distant third in this space.
  • Closed System Transfer Devices (CSTDs): CSTDs protect healthcare workers from exposure to hazardous drugs during compounding and administration. Key competitor in this space is BD. This is one of ICU Medical's stronger sectors where they are a clear leader.

Market Dynamics

industry overview logo Industry Overview

The medical device industry is characterized by technological innovation, stringent regulatory requirements, and increasing demand for advanced healthcare solutions. Trends include connected devices, personalized medicine, and a focus on patient safety.

Positioning

ICU Medical is positioned as a leading provider of infusion therapy and critical care products. Its competitive advantages include a broad product portfolio, a strong reputation for quality and innovation, and a global distribution network.

Total Addressable Market (TAM)

The TAM is estimated to be in the tens of billions of USD. ICU Medical is well-positioned to capture a significant portion of the TAM, particularly in its core infusion therapy and medication delivery segments.

Upturn SWOT Analysis

Strengths

  • Strong brand reputation
  • Broad product portfolio
  • Global distribution network
  • Focus on innovation
  • Strong financial performance

Weaknesses

  • Reliance on a few key products
  • Integration challenges related to acquisitions
  • Exposure to regulatory risks
  • Dependence on hospital capital spending

Opportunities

  • Expanding into emerging markets
  • Developing new products and technologies
  • Acquiring complementary businesses
  • Partnering with other healthcare providers

Threats

  • Increasing competition
  • Pricing pressures
  • Technological obsolescence
  • Changes in healthcare regulations

Competitors and Market Share

competitor logo Key Competitors

  • BAX
  • BDX
  • FMS

Competitive Landscape

ICU Medical competes with larger medical device companies. Their strengths include focused expertise and specialty products, while their disadvantages include smaller scale and less diversification.

Major Acquisitions

Smiths Medical

  • Year: 2022
  • Acquisition Price (USD millions): 2350
  • Strategic Rationale: Expanded ICU Medical's global reach and product portfolio in infusion therapy and vascular access.

Growth Trajectory and Initiatives

Historical Growth: ICU Medical has grown through organic product development and strategic acquisitions.

Future Projections: Future growth projections depend on analyst estimates and market conditions. See analyst reports for details.

Recent Initiatives: Recent initiatives include new product launches, expansion into new markets, and strategic acquisitions.

Summary

ICU Medical is a reputable medical device company that is positioned in the infusion market. With the acquisition of Smiths Medical, they have an expanded offering that will need to be integrated. While they face stiff competition, their continued focus on innovation and acquisitions sets them up for future growth. The company needs to be mindful of the market leaders in infusion products. There also need to be more revenue-generating avenues outside of M&A.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings (10-K, 10-Q)
  • Industry Reports
  • Analyst Reports
  • Press Releases
  • Company Website

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Market conditions and company performance are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About ICU Medical Inc

Exchange NASDAQ
Headquaters San Clemente, CA, United States
IPO Launch date 1992-03-31
CEO & Chairman of the Board Mr. Vivek Jain
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 15000
Full time employees 15000

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.